Company Snapshot
- Ticker
- DHR
- Name
- DHR
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 160852731000.000000
- Volume
- 4,858,304
- Avg Volume (3M)
- 3,916,931
DHR
DHR
Last update recent
226.33
-6.04
(-2.60%)
Market Cap
160852731000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 24268000000.000000
- EPS
- 4.88
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.53%
- Net Income
- 3503000000.000000
- Net Margin
- 14.43%
- Payout Ratio
- 24.18%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 45.92
- Forward P/E
- None
- P/S
- 6.63
- P/B
- 3.15
- Beta
- None
- Debt / Equity
- 0.33
- Current Ratio
- 1.52
- Return on Equity
- 0.07%
- Return on Assets
- 0.04%
Technicals & Returns
- Distance vs 200 DMA
- 11.47%
- 200 DMA
- 203.05
- Distance vs 50 DMA
- 3.73%
- 50 DMA
- 218.20
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies Read more
- Name
- DHR
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Rainer M. Blair
- Employees
- 61,000
- IPO Date
- 1978-12-29
- Phone
- 202 828 0850
- Address
- None
- Website
- https://www.danaher.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-06-28 • $0.27
Latest News
Curated headlines from premium sources.
Rep. Julie Johnson Sells Off Shares of Danaher Corporation (NYSE:DHR)
Representative Julie Johnson (D-Texas) recently sold shares of Danaher Corporation (NYSE: DHR). In a filing disclosed on December 11th, the Representative disc…
Geneos Wealth Management Inc. Purchases 10,257 Shares of Danaher Corporation $DHR
Geneos Wealth Management Inc. boosted its holdings in Danaher Corporation (NYSE: DHR) by 56.1% in the second quarter, according to its most recent filing with …
Danaher Corporation $DHR Stake Reduced by BlueSpruce Investments LP
BlueSpruce Investments LP cut its holdings in Danaher Corporation (NYSE: DHR) by 4.2% during the undefined quarter, according to its most recent Form 13F filin…
Federated Hermes Inc. Sells 64,794 Shares of Danaher Corporation $DHR
Federated Hermes Inc. cut its holdings in shares of Danaher Corporation (NYSE: DHR) by 31.1% during the undefined quarter, according to its most recent disclos…
Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value
Danaher Corporation is rated Buy with a target price of $250, implying 10.5% upside from $226.25. DHR's strong Q3 execution featured 4.5% revenue growth, margi…
Bank of Nova Scotia Reduces Stake in Danaher Corporation $DHR
Bank of Nova Scotia cut its holdings in shares of Danaher Corporation (NYSE: DHR) by 7.0% during the undefined quarter, according to its most recent Form 13F f…